Article
Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.
Cells - 28 Oct 2020
Stackhouse Christian T, Gillespie G Yancey, Willey Christopher D
Abstract excerpt
Glioblastoma (GBM) remains the most devastating primary central nervous system malignancy with a median survival of around 15 months. The past decades of research have not yielded significant advancements in the treatment of GBM. In that same time, a novel class of molecules, long non-coding RNAs (lncRNAs), has been found to play a multitude of roles in cancer and normal biology. The increased accessibility of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
